Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus

被引:14
|
作者
Gautam, Avishekh [1 ]
Parke, Byoung Kwon [2 ]
Kim, Te Ha [1 ]
Akauliya, Madhav [1 ]
Kim, Dongbum [2 ]
Maharjan, Sony [2 ]
Park, Joongwon [1 ]
Kim, Jinsoo [1 ]
Lee, Hanseul [1 ]
Park, Man-Seong [3 ,4 ]
Lee, Younghee [5 ]
Kwon, Hyung-Joo [1 ,2 ]
机构
[1] Hallym Univ, Dept Microbiol, Coll Med, Chunchon, South Korea
[2] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon, South Korea
[3] Korea Univ, Dept Microbiol, Coll Med, Seoul, South Korea
[4] Korea Univ, Inst Viral Dis, Seoul, South Korea
[5] Chungbuk Natl Univ, Dept Biochem, Coll Nat Sci, Cheongju, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
基金
新加坡国家研究基金会;
关键词
apoptosis; cross protection; influenza A virus; neutralizing antibody; peritoneal cells; ANIMAL-MODELS; INFECTION; MICE; PATHOGENESIS; TRANSMISSION; RECEPTOR; H5N1; IMMUNIZATION; MACROPHAGES; APOPTOSIS;
D O I
10.3389/fimmu.2019.01160
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intraperitoneal inoculation with live influenza A virus confers protection against intranasal infections in mice and ferrets. However, the responses of peritoneal cells to influenza A virus have not been investigated. Here we show that intraperitoneal inoculation with ANVSN/1933 (H1N1) virus induced virus-reactive IgG production in the peritoneal cavity in mice. The infection resulted in substantial but transient B cell and macrophage depletion along with massive neutrophil infiltration, but virus growth was not detected. Influenza A viruses bound to alpha-2,6-linked sialic acids of B cells and macrophages and induced apoptotic death of peritoneal cavity cells. However, re-infection with A/WSN/1933 virus did not have adverse effects on immune cells most likely because of the neutralizing antibodies produced in response to the first exposure. Infection of BALB/c mice with ANVSN/1933 induced cross-protection against an otherwise lethal intraperitoneal dose of A/Hongkong/4801/2014 (H3N2) virus. This information suggests that immunological responses in the peritoneal cavity can induce effective defense against future virus infection. Considering the unexpected potent immunoregulatory activity of the peritoneal cells against influenza viruses, we suggest that comparative studies on various immune reactions after infection through different routes may contribute to better selection of vaccination routes in development of efficacious influenza vaccines.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase
    Chen, Z
    Kadowaki, S
    Hagiwara, Y
    Yoshikawa, T
    Matsuo, K
    Kurata, T
    Tamura, S
    VACCINE, 2000, 18 (28) : 3214 - 3222
  • [2] ADCC: An underappreciated correlate of cross-protection against influenza?
    de Vries, Rory D.
    Hoschler, Katja
    Rimmelzwaan, Guus F.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge
    Wen, Jinsheng
    Ngono, Annie Elong
    Regla-Nava, Jose Angel
    Kim, Kenneth
    Gorman, Matthew J.
    Diamond, Michael S.
    Shresta, Sujan
    NATURE COMMUNICATIONS, 2017, 8
  • [4] Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge
    Jinsheng Wen
    Annie Elong Ngono
    Jose Angel Regla-Nava
    Kenneth Kim
    Matthew J. Gorman
    Michael S. Diamond
    Sujan Shresta
    Nature Communications, 8
  • [5] Vaccine approaches conferring cross-protection against influenza viruses
    Vemula, Sai V.
    Sayedahmed, Ekramy E.
    Sambhara, Suryaprakash
    Mittal, Suresh K.
    EXPERT REVIEW OF VACCINES, 2017, 16 (11) : 1141 - 1154
  • [6] Immune mechanisms associated with enhanced influenza A virus disease versus cross-protection in vaccinated pigs.
    Hughes, Holly
    Olson, Zahra
    Gauger, Phillip
    Vincent, Amy
    Brockmeier, Susan
    Loving, Crystal
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [7] Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus
    Asahi-Ozaki, Y
    Yoshikawa, T
    Iwakura, Y
    Suzuki, Y
    Tamura, S
    Kurata, T
    Sata, T
    JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (02) : 328 - 335
  • [8] CROSS-PROTECTION AGAINST INFLUENZA-VIRUS INFECTION IN MICE VACCINATED BY COMBINED NASAL SUBCUTANEOUS ADMINISTRATION
    ASANUMA, H
    KOIDE, F
    SUZUKI, Y
    NAGAMINE, T
    AIZAWA, C
    KURATA, T
    TAMURA, S
    VACCINE, 1995, 13 (01) : 3 - 5
  • [9] Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA
    Zhu, Hechao
    Li, Xiangmin
    Ren, Xujiao
    Chen, Huanchun
    Qian, Ping
    VACCINE, 2022, 40 (44) : 6352 - 6361
  • [10] CROSS-PROTECTION AGAINST VIRUS DISEASES IN FRUIT-TREES
    ALREFAI, RH
    KORBAN, SS
    FRUIT VARIETIES JOURNAL, 1995, 49 (01): : 21 - 30